Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2020. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5089015015 | Diphtheria toxoid, Haemophilus influenzae type b conjugate, hepatitis B surface antigen, acellular pertussis and tetanus toxoid pediatric vaccine | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 5089016019 | Diphtheria toxoid, Haemophilus influenzae type b conjugate, hepatitis B surface antigen, acellular pertussis and tetanus toxoid paediatric vaccine | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 5089017011 | Acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b capsular polysaccharide conjugated, Hepatitis B virus surface antigens only pediatric vaccine | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 5089018018 | Pediatric vaccine product containing only acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b capsular polysaccharide conjugated, Hepatitis B virus surface antigens (medicinal product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT core module |
| 5089019014 | Acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b capsular polysaccharide conjugated, Hepatitis B virus surface antigens only paediatric vaccine | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Pediatric vaccine product containing only acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b capsular polysaccharide conjugated, Hepatitis B virus surface antigens (medicinal product) | Is a | Vaccine product containing Clostridium tetani toxoid antigen (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Pediatric vaccine product containing only acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b capsular polysaccharide conjugated, Hepatitis B virus surface antigens (medicinal product) | Count of base of active ingredient | 5 | false | Inferred relationship | Existential restriction modifier | ||
| Pediatric vaccine product containing only acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b capsular polysaccharide conjugated, Hepatitis B virus surface antigens (medicinal product) | Is a | Vaccine product containing Corynebacterium diphtheriae toxoid antigen (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Pediatric vaccine product containing only acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b capsular polysaccharide conjugated, Hepatitis B virus surface antigens (medicinal product) | Has product characteristic | Childhood | false | Inferred relationship | Existential restriction modifier | ||
| Pediatric vaccine product containing only acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b capsular polysaccharide conjugated, Hepatitis B virus surface antigens (medicinal product) | Plays role | Active immunity stimulant role | true | Inferred relationship | Existential restriction modifier | ||
| Pediatric vaccine product containing only acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b capsular polysaccharide conjugated, Hepatitis B virus surface antigens (medicinal product) | Has active ingredient | Diphtheria toxoid | true | Inferred relationship | Existential restriction modifier | 1 | |
| Pediatric vaccine product containing only acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b capsular polysaccharide conjugated, Hepatitis B virus surface antigens (medicinal product) | Has active ingredient | Antigen of Hepatitis B virus surface protein | true | Inferred relationship | Existential restriction modifier | 2 | |
| Pediatric vaccine product containing only acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b capsular polysaccharide conjugated, Hepatitis B virus surface antigens (medicinal product) | Has active ingredient | Antigen of Clostridium tetani toxoid | true | Inferred relationship | Existential restriction modifier | 3 | |
| Pediatric vaccine product containing only acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b capsular polysaccharide conjugated, Hepatitis B virus surface antigens (medicinal product) | Has active ingredient | Antigen of Haemophilus influenzae type b capsular polysaccharide conjugated | true | Inferred relationship | Existential restriction modifier | 4 | |
| Pediatric vaccine product containing only acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b capsular polysaccharide conjugated, Hepatitis B virus surface antigens (medicinal product) | Has active ingredient | Antigen of acellular Bordetella pertussis | true | Inferred relationship | Existential restriction modifier | 5 | |
| Pediatric vaccine product containing only acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b capsular polysaccharide conjugated, Hepatitis B virus surface antigens (medicinal product) | Is a | Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Pediatric vaccine product containing only acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b capsular polysaccharide conjugated, Hepatitis B virus surface antigens (medicinal product) | Has target population | Pediatric population | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR